DoD Ovarian Cancer Research Program Pilot Award
ID: 353195Type: Posted
Overview

Buyer

Dept. of the Army -- USAMRAA (DOD-AMRAA)

Eligible Applicants

Unrestricted

Funding Category

Science and Technology and other Research and Development

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/353195
Timeline
    Description

    The Department of the Army, through the U.S. Army Medical Research and Materiel Command (USAMRAA), has announced the FY24 Ovarian Cancer Research Program (OCRP) Pilot Award, aimed at fostering innovative research in ovarian cancer prevention, diagnosis, treatment, and survivorship. This grant opportunity, totaling approximately $4.8 million, encourages proposals that explore novel concepts or theories related to ovarian cancer, with a focus on utilizing relevant tissues, cell lines, datasets, or animal models to drive significant advancements in the field. Interested applicants, including both intramural and extramural organizations, must submit pre-applications by May 14, 2024, and full applications by August 6, 2024, with no cost-sharing required. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.

    Point(s) of Contact
    help@eBRAP.org
    Files
    Title
    Posted
    HT9425-24-OCRP-PA_GG.pdf
    The Department of Defense (DOD) has announced the FY24 Ovarian Cancer Pilot Award under the Ovarian Cancer Research Program (OCRP), aimed at promoting innovative research to prevent, diagnose, treat, and improve survivorship for ovarian cancer. This funding opportunity, which totals $45 million, emphasizes patient-centered approaches and targets critical areas such as understanding ovarian cancer biology, developing novel therapies, and addressing health disparities. Pre-applications are due by May 14, 2024, with full applications due by August 6, 2024. Eligible applicants include both intramural and extramural organizations with no cost-sharing required. Each application must demonstrate innovation and propose research with a clear hypothesis. Notably, clinical trials are excluded from this funding mechanism. The proposal process comprises a two-step submission through the Electronic Biomedical Research Application Portal (eBRAP) and Grants.gov. Researchers will undergo peer and programmatic reviews to ensure that funds are allocated based on scientific merit and alignment with federal priorities. Funding decisions will be contingent on available federal funds, emphasizing the DOD's commitment to impactful ovarian cancer research for military personnel, veterans, and the general public.
    Similar Opportunities
    DOD Pancreatic Cancer, Focused Pilot Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Materiel Command (USAMRAA), is inviting applications for the FY24 Pancreatic Cancer Focused Pilot Award, aimed at fostering innovative research to enhance the diagnosis, therapy, and overall outcomes for pancreatic cancer patients. This grant supports projects that explore impactful concepts in two specific focus areas: supportive care interventions during various phases of cancer care and strategies to address healthcare implementation barriers. With an estimated total program funding of $1.28 million and the expectation of awarding four grants, applicants must submit a Letter of Intent by September 18, 2024, followed by a full application due by October 3, 2024. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
    DoD Peer Reviewed Cancer, Advancing Cancer Care Through Clinical Trials Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering a grant opportunity titled "DoD Peer Reviewed Cancer, Advancing Cancer Care Through Clinical Trials Award" for Fiscal Year 2024. This funding initiative aims to support the rapid implementation of clinical trials that have the potential to significantly impact cancer treatment and management, particularly for military personnel and their families, addressing specific topic areas related to military health. With an estimated total program funding of $24 million and the expectation of awarding up to five grants, eligible applicants can submit proposals that demonstrate the feasibility and relevance of their clinical trials, with a maximum award amount of $3 million. Interested parties must submit their applications by October 15, 2024, and can reach out to the CDMRP Help Desk at help@eBRAP.org for further assistance.
    DoD Peer Reviewed Cancer, Impact Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Materiel Command (USAMRAA), is offering the FY24 Peer Reviewed Cancer Impact Award, aimed at funding high-impact cancer research that benefits Service Members, Veterans, and their families. This grant opportunity seeks to support mature research projects that address critical cancer issues, with a focus on translational or clinical research that demonstrates the potential for significant near-term impact on patient outcomes. With an estimated total program funding of $16 million and the expectation of awarding approximately 10 grants, applicants must submit a pre-application by June 21, 2024, followed by a full application due by September 26, 2024. For further inquiries, interested parties can contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
    DoD Rare Cancers, Resource Community Development Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the U.S. Army Medical Research Acquisition Activity, is offering the FY24 Rare Cancers Resource and Community Development Award to support research initiatives aimed at improving outcomes for individuals with rare cancers. This grant opportunity seeks to develop clinical or preclinical datasets and research resources that address significant gaps in rare cancer research, emphasizing collaboration among researchers, patients, and clinicians, with a mandatory inclusion of patient advocates in the project planning and implementation phases. With an estimated total funding of $6.4 million available for up to five awards, each project can receive a maximum of $800,000 over a four-year period. Interested applicants must submit a pre-application followed by a full application, with the submission deadline set for September 23, 2024. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
    DoD Rare Cancers, Idea Development Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the Congressionally Directed Medical Research Programs (CDMRP), is offering the Fiscal Year 2024 Rare Cancers Idea Development Award to support innovative research aimed at advancing the understanding and treatment of rare cancers. This grant opportunity encourages proposals that focus on understanding molecular pathways, developing tumor-specific models, or identifying novel therapies, with an emphasis on research that can significantly impact patient outcomes. The total funding available for this program is approximately $17.5 million, with individual awards capped at $350,000 over a three-year period, and applications are due in two stages: a pre-application by June 17, 2024, and a full application by September 23, 2024. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or by phone at 301-682-5507.
    DOD Pancreatic Cancer, Idea Development Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the U.S. Army Medical Research and Materiel Command (USAMRAA), is offering the Fiscal Year 2024 Pancreatic Cancer Research Program (PCARP) Idea Development Award, aimed at supporting innovative research projects that advance the understanding and treatment of pancreatic cancer. This grant opportunity encourages high-risk, high-reward studies that could lead to significant breakthroughs in early detection, supportive care, and the underlying mechanisms of pancreatic cancer, with a total estimated funding of $7.36 million available for approximately eight awards. Eligible applicants include both established and early-career investigators, with a maximum funding limit of $500,000 for single Principal Investigator (PI) applications and $650,000 for partnered applications, emphasizing the importance of collaboration in research efforts. Interested parties should note that the application deadline is October 3, 2024, with a pre-application deadline of June 28, 2024, and can reach out to the CDMRP Help Desk at help@eBRAP.org for further assistance.
    DoD Breast Cancer, Clinical Research Extension Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Materiel Command (USAMRAA), is offering the FY24 Breast Cancer Clinical Research Extension Award, a federal grant aimed at enhancing the impact of breast cancer clinical studies. This grant seeks to extend data collection and analysis from existing clinical trials, focusing on improving patient follow-up and addressing knowledge gaps due to early trial terminations. The program is critical for advancing breast cancer research and ensuring that patient contributions are effectively utilized to save lives. With an estimated total funding of $9.3 million, the award will support one application, with a maximum budget of $5 million for single Principal Investigators or $6 million for those utilizing the Partnering PI option. Interested applicants must submit a pre-application by September 12, 2024, and a full application by September 26, 2024. For further inquiries, contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
    DOD Pancreatic Cancer, Translational Research Partnership Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the FY24 Pancreatic Cancer Translational Research Partnership Award, aimed at fostering innovative collaborations between clinician investigators and research scientists to advance pancreatic cancer research. This grant supports projects that require equal contributions from both partners, focusing on critical areas such as early detection, supportive care interventions, and drug resistance mechanisms, with an emphasis on translating scientific discoveries into clinical applications. The total funding available for this opportunity is $4.8 million, with individual proposals eligible for up to $750,000, and the application process involves a two-step submission via eBRAP and Grants.gov, with a closing date of October 3, 2024. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
    DoD Peer Reviewed Cancer Convergent Science Cancer Consortium Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the DoD Peer Reviewed Cancer Convergent Science Cancer Consortium Award (CSCCA) for Fiscal Year 2024. This grant aims to foster transdisciplinary collaborations among scientists, clinicians, and consumer advocates to address urgent issues in cancer research, specifically targeting at least three distinct cancer areas while integrating diverse scientific methodologies. With an estimated total program funding of $32 million and a single award anticipated, applicants must submit a pre-application followed by a full application upon invitation, with the closing date for submissions set for October 15, 2024. For further inquiries, interested parties can contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
    DoD Peer Reviewed Orthopaedic, Clinical Trial Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the Congressionally Directed Medical Research Programs (CDMRP), is offering the Fiscal Year 2024 (FY24) Peer Reviewed Orthopaedic Clinical Trial Award aimed at enhancing recovery from combat-related orthopaedic injuries. This grant supports clinical trials that focus on innovative treatment strategies, including limb stabilization, battlefield care, and rehabilitation, with an emphasis on interdisciplinary collaboration to improve military readiness and patient care. With an estimated total program funding of $13.25 million, the program anticipates awarding up to four grants of $2.5 million each for standard projects and one grant of $3.25 million for collaborative care projects. Interested applicants must submit pre-applications by June 18, 2024, and full applications by September 17, 2024; for further inquiries, contact the CDMRP Help Desk at help@eBRAP.org.